Open in app
Home
Notifications
Lists
Stories

Write
Ross V. Chikarmane
Ross V. Chikarmane

Home
About

May 13

Money in Politics

A data-driven profile on major sources of campaign financing for U.S. Congressional & Presidential elections and their influence on outcomes. “We make a living by what we get, but we make a life by what we give.” Winston Churchill, Prime Minister of U.K. It’s the most wonderful time of the…

Politics

17 min read

Money in Politics
Money in Politics

Mar 19

A Memoir on Building Hopkins Biotech Podcast

How we built the Hopkins Biotech Podcast — based out of Johns Hopkins School of Medicine — and grew it from a simple idea to a program with >23,000 lifetime downloads, >5,600 pageviews, and >850 aggregate followers in less than 2 years. Part 1: Conceiving the Idea “If you are working on something exciting that…

Science

23 min read

A Memoir on Building Hopkins Biotech Podcast
A Memoir on Building Hopkins Biotech Podcast

Nov 6, 2021

PhD Career Prospects by the Numbers

A data-driven profile on the types of work that STEM PhDs pursue and their pay scales, based on employment statistics from the National Science Foundation (NSF) and U.S. Department of Labor. View graphs only here. Part 1: Labor Supply & Demand PhDs Contribute to Strong Labor Supply in Technical Professions The labor force participation rate is the percentage of the U.S. population who are either…

8 min read

PhD Career Prospects by the Numbers
PhD Career Prospects by the Numbers

Published in The Startup

·Dec 31, 2020

Biotech Investment Surges in 2020

In honor of the last trading day of 2020, let’s review this year in biotech investing. On March 5, six days before the WHO officially recognized COVID-19 as a global pandemic, the United States recorded 174 total confirmed cases within its borders. On that same day, the investment team at…

Biotechnology

6 min read

Biotech Investment Surges in 2020
Biotech Investment Surges in 2020

Published in The Startup

·Dec 25, 2020

Foghorn Therapeutics Breaks New Ground in Cancer Epigenetics

Originally published on December 2, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) Since the emergence of “modern medicine” in the 19th century, biomedical researchers have uncovered insights that drastically improved the way we treat cancer. Surgical procedures for removing tumor-bearing organs, as well as radiation therapies, started to become…

Biotechnology

5 min read

Foghorn Therapeutics Breaks New Ground in Cancer Epigenetics
Foghorn Therapeutics Breaks New Ground in Cancer Epigenetics

Published in The Startup

·Dec 25, 2020

Next Generation Cancer Diagnostics Revolutionize Patient Care

Originally published on October 5, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) On April 15, 2003, the Human Genome Project was officially declared “complete” after generating a reference sequence for approximately 92.1% of the more than 3.1 billion base pairs that comprise the human genome1. By meticulously cataloging the…

Biotechnology

7 min read

Next Generation Cancer Diagnostics Revolutionize Patient Care
Next Generation Cancer Diagnostics Revolutionize Patient Care

Dec 25, 2020

How to Master a New Technique

Originally published on August 3, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) In a 2016 interview, Mark Zuckerberg — the co-founder, chairman and CEO of Facebook — reflected on a particularly impactful piece of advice that he had received from a mentor: “In a world that’s changing so quickly…

Biotechnology

6 min read

How to Master a New Technique
How to Master a New Technique

Dec 25, 2020

Why Leave Career Fulfillment Up to Chance?

Originally published on June 24, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) to promote the Hopkins Biotech Podcast, which we had launched ~1 month previously on May 25, 2020 (Memorial Day) “Shallow men believe in luck. Strong men believe in cause & effect” Ralph Waldo Emerson Which career is…

Biotech

5 min read

Why Leave Career Fulfillment Up to Chance?
Why Leave Career Fulfillment Up to Chance?

Dec 25, 2020

Every Challenge Is an Opportunity

Originally published on April 21, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) In my experience, the term “smooth sailing” is an expression used to describe those rare moments that occur shortly before being bombarded by the next big wave. Challenges are inevitable, particularly for those working in STEM fields…

Pharma

5 min read

Every Challenge Is an Opportunity
Every Challenge Is an Opportunity

Dec 25, 2020

An Alzheimer’s Drug Rises from the Ashes

Originally published on April 11, 2020 in Hopkins Biotech Network’s newsletter The Transcript (link) Memories have a curious way of rising to the surface. Some memories are so salient that even the most subtle sensations — the aroma of freshly baked bread, a wafting perfume, a chorus of light rain…

Biotechnology

10 min read

An Alzheimer’s Drug Rises from the Ashes
An Alzheimer’s Drug Rises from the Ashes
Ross V. Chikarmane

Ross V. Chikarmane

Associate at RA Capital Management | PhD, Johns Hopkins Medicine

Following
  • Scott Galloway

    Scott Galloway

  • Dave Friedberg

    Dave Friedberg

  • Simon Barnett

    Simon Barnett

  • Nathaniel Brooks Horwitz

    Nathaniel Brooks Horwitz

  • Sam Altman

    Sam Altman

Help

Status

Writers

Blog

Careers

Privacy

Terms

About

Knowable